Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 6.49Sigachi Industries demonstrates a mixed financial profile. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient operations. Growth prospects are robust, driven by impressive revenue and asset expansion. However, efficiency metrics reveal challenges in asset utilization, particularly in fixed assets and working capital management. Liquidity is reasonably managed, though operating cash flow needs attention. Financial metrics such as EPS and capital expenditure scores are relatively low, suggesting areas for improvement in shareholder value and investment strategies. Overall, while the company shows considerable promise and strong financial health in some areas, there are operational inefficiencies that need to be addressed to ensure sustained success.
Health Score : 6.49Sigachi Industries demonstrates a mixed financial profile. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient operations. Growth prospects are robust, driven by impressive revenue and asset expansion. However, efficiency metrics reveal challenges in asset utilization, particularly in fixed assets and working capital management. Liquidity is reasonably managed, though operating cash flow needs attention. Financial metrics such as EPS and capital expenditure scores are relatively low, suggesting areas for improvement in shareholder value and investment strategies. Overall, while the company shows considerable promise and strong financial health in some areas, there are operational inefficiencies that need to be addressed to ensure sustained success.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-15.25
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
-14.82
P/B RATIO
2.33
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
2.53
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-21.19
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹31.72 as on Sep 1, 2026.
Growth Score : 8.00The company demonstrates strong growth in revenue, operating profit, assets, and net income. However, the negative EPS growth indicates potential challenges in translating growth into shareholder value. The company has a good growth in revenue and operating profit. The company has to work on its EPS growth so that shareholder value can be increased and maintained.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 29.53 | 20.8 | 32.12 | 22.31 | -2.05 |
| Operating Profit Growth Rate | 35.9 | 11.32 | 30.51 | 29.87 | -46 |
| Earnings Per Share (EPS) Growth | -67.01 | -100 | 4.6 | -217.58 | |
| Asset Growth Rate | 115.79 | 30.31 | 85.56 | 21.9 | -0.59 |
| Net Income Growth Rate | 33.33 | 10 | 29.55 | 22.81 | -218.57 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 37.27 | Overvalued | 58.00 | 6.54 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 70.69 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 4 | Windlas Biotech Ltd | 7.52 | 32.03 | Neutral | 105.00 | 32.19 | 66.00 |
| 5 | Lincoln Pharmaceuticals Ltd | 7.31 | 13.89 | Neutral | 98.00 | 43.88 | 88.00 |
| 6 | Kilitch Drugs (India) Ltd | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 7 | NGL Fine Chem Ltd | 6.98 | 34.11 | Neutral | 73.00 | 67.39 | 48.00 |
| 8 | Syncom Formulations (India) Ltd | 6.92 | 24.78 | Neutral | 77.00 | 0.81 | 76.00 |
| 9 | Sakar Healthcare Ltd | 6.89 | 70.49 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 10 | Kopran Ltd | 6.60 | 40.82 | Undervalued | 62.00 | 6.30 | 26.00 |
| 11 | Hester Biosciences Ltd | 6.54 | 33.64 | Neutral | 87.00 | 61.24 | 57.00 |
| 12 | Sigachi Industries Ltd | 6.49 | -14.82 | Neutral | 54.00 | -2.08 | -83.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 27.61 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 77.18 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 27.30 | Neutral | 88.00 | 15.98 | 43.00 |
| 17 | Solara Active Pharma Sciences Ltd | 4.34 | -313.88 | Neutral | 187.00 | -1.50 | -7.00 |
| 18 | NOVARTIND | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Sigachi Industries Ltd. is a leading Indian manufacturer of Microcrystalline Cellulose (MCC), a critical excipient and additive used extensively in pharmaceutical, food, and cosmetic industries. The company holds a significant market position in India, known for its diverse grades of MCC and other cellulose-based products.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Sigachi Industries Ltd's P/E ratio (TTM) is -15.25, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Sigachi Industries Ltd's P/B ratio is 2.33, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Sigachi Industries Ltd's P/S ratio is 2.53, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Sigachi Industries Ltd's PEG ratio is 2.20.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Sigachi Industries Ltd's EV/EBITDA ratio is -21.19.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Sigachi Industries Ltd's ROE is -15.90%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Sigachi Industries Ltd's ROA is 6.42%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Sigachi Industries Ltd's ROCE is 6%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Sigachi Industries Ltd's operating margin is 11.30%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Sigachi Industries Ltd's net margin is -17.36%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Sigachi Industries Ltd's current ratio is 1.53.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Sigachi Industries Ltd's debt-to-equity ratio is 0.01.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Sigachi Industries Ltd's interest coverage ratio is -5.29.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Sigachi Industries Ltd's DPS is ₹0.11.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Sigachi Industries Ltd's EPS is -217.58.
(Source line: "Ratios as of 26 Sept 2026, based on last traded price of ₹31.72. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1989
Headquarters: Hyderabad, Telangana
Core Offerings: Microcrystalline Cellulose (MCC), Cellulose Powder, Carboxymethyl Cellulose (CMC), Excipients for Pharma and Food
Stock Listing: NSE (SIGACHI), BSE (543389)
Promoter: Sarveswar Reddy & Promoter Group
1989: Incorporated as Sigachi Industries Private Limited. Mid-1990s - 2010s: Focused on expanding manufacturing capacity and product portfolio, establishing itself as a key supplier of Microcrystalline Cellulose (MCC) in India. 2021: Converted to a public limited company and successfully launched its Initial Public Offering (IPO), listing on NSE and BSE. Present: Continues to be a leading manufacturer of MCC for diverse industries globally, investing in capacity expansion and product diversification.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Microcrystalline Cellulose (MCC) & Cellulose-based Excipients | 95%+ | Primary revenue and profit driver |
Mr. Sarveswar Reddy, Chairman & Managing Director. A first-generation entrepreneur with over three decades of experience in the cellulose and chemical industry, leading Sigachi's growth and market leadership.
2021**: Initial Public Offering (IPO) on NSE & BSE. 2023: Bonus Issue in ratio of 1:4 (1 equity share for every 4 held).
The Sigachi Industries Ltd share price today is ₹31.72 on NSE (SIGACHI), as of 26 Sept 2026.
As of 26 Sept 2026, Sigachi Industries Ltd share price is ₹31.72, with previous close ₹31.72. Today's range is ₹31.72 to ₹31.72. The 52-week range is ₹16.65 to ₹40.80.
As of today, Sigachi Industries Ltd's market cap is ₹1,209.8 crore (Small Cap).
Sigachi Industries Ltd's current P/E ratio is -15.25, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 36.
Sigachi Industries Ltd's current P/B ratio is 2.33.
Sigachi Industries Ltd's current dividend yield is 0.35%. Last dividend of ₹1.00 per share was declared on 02-Aug-2024.
Sigachi Industries Ltd's EPS (TTM) is ₹-217.58.
Sigachi Industries Ltd. is a leading Indian manufacturer of Microcrystalline Cellulose (MCC), a critical excipient and additive used extensively in pharmaceutical, food, and cosmetic industries. The company holds a significant market position in India, known for its diverse grades of MCC and other cellulose-based products.
Sigachi Industries Ltd is promoted by Sarveswar Reddy & Promoter Group, holding 36.69% as of 26 Sept 2026.
Sigachi Industries Ltd is listed on NSE (SIGACHI) and BSE (543389). Its next quarterly results are expected on August 2024.
Cash Earnings Per Share (Cash EPS)
